Millipore Sigma Vibrant Logo

MABT397 Anti-CEACAM1/CD66a Antibody, clone B3-17

View This Product on Sigma-Aldrich
MABT397
100 µg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HELISA, FC, ICC, IH(P), WBMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABT397
      DescriptionAnti-CEACAM1/CD66a Antibody, clone B3-17
      Alternate Names
      • Carcinoembryonic antigen-related cell adhesion molecule 1
      • Biliary glycoprotein 1
      • BGP-1
      • CD66a
      Background InformationCEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1) is thought to be a member of the immunoglobulin superfamily and is known as an epithelial tumor suppressor and an angiogenic growth factor. It has also been linked to the actin-based cytoskeleton. CEACAM1 is also known as a cellular receptor for a number of human mucosa pathogenic bacteria. The loss of activity of CEACAM1 has been related to the development of colorectal cancer.
      References
      Product Information
      FormatPurified
      PresentationPurified mouse IgG1κ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationThis Anti-CEACAM1/CD66a Antibody, clone B3-17 is validated for use in ELISA, Flow Cytometry, Immunocytochemistry, Immunohistochemistry, and Western Blotting for the detection of human CEACAM1/CD66a.
      Key Applications
      • ELISA
      • Flow Cytometry
      • Immunocytochemistry
      • Immunohistochemistry (Paraffin)
      • Western Blotting
      Application NotesELISA Analysis: 10 µg/mL from a representative lot detected human CEACAM1/CD66a by ELISA (Courtesy of Dr. B. Singer, University Duisburg-Essen, Germany).

      Flow Cytometry Analysis: 10 µg/mL from a representative lot detected the exogenously expressed human CEACAM1/CD66a on the surface of transfected HeLa cells (Courtesy of Dr. B. Singer, University Duisburg-Essen, Germany).

      Immunocytochemistry Analysis: 10 µg/mL from a representative lot detected CEACAM1/CD66a on the surface of HT-29 human colorectal carcinoma cells (Courtesy of Dr. B. Singer, University Duisburg-Essen, Germany).

      Immunohistochemistry Analysis: 10 µg/mL from a representative lot detected CEACAM1/CD66a immunoreactivity in human jejunum tissue (Courtesy of Dr. B. Singer, University Duisburg-Essen, Germany).

      Western Blotting Analysis: 10 µg/mL from a representative lot detected the exogensously expressed human CEACAM1/CD66a extracellular domain-Fc fusion in lysates from transfected cells (Courtesy of Dr. B. Singer, University Duisburg-Essen, Germany).

      Flow Cytometry Analysis: Representative lots, either unconjugated or FITC-conjugated, detected CECAM1 immunoreactivity on the surface of human peripheral blood naïve and memory B-cells (Khairnar, V., et al. (2015). Nat. Commun. 6:6217; Seifert, M., et al. (2015). Proc. Natl. Acad. Sci. 112(6):E546-555).

      Flow Cytometry Analysis: A representative lot detected CEACAM1/CD66a induction on the surface of normal human bronchial epithelial (NHBE) cells stimulated with poly(I:C) or interferons (Klaile, E., et al. (2013) Respir Res. 14:85).

      Flow Cytometry Analysis: A representative lot detected CEACAM1/CD66a expression on the surface of 2 day-starved human epithelial (HT29, T102/3) and endothelial (AS-M.5) cells, as well as multivesicular bodies (MVBs) derived from these cells (Muturi H.T., et al. (2013) PLoS One. 8(9):e74654).

      Immunocytochemistry Analysis: A representative lot detected CEACAM1/CD66a immunoreactivity on the surface of normal human bronchial epithelial (NHBE) cells by indirect immunofluorescence staining (Klaile, E., et al. (2013) Respir Res. 14:85).

      Immunohistochemistry Analysis: A representative lot detected CEACAM1/CD66a in paraffin-embedded human lung cancer tissue sections (Klaile, E., et al. (2013) Respir Res. 14:85).

      Western Blot Analysis: A representative lot detected CEACAM1/CD66a in 2 day-starved AS-M.5 human endothelialn cells and AS-M.5-derived multivesicular bodies (MVBs) (Muturi H.T., et al. (2013) PLoS One. 8(9):e74654).
      Biological Information
      ImmunogenRecombinant human CEACAM1/CD66a.
      EpitopeExtracellular domain.
      CloneB3-17
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      IsotypeIgG1κ
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • CEACAM1
      • BGP
      • BGP1
      Purification MethodProtein G purified.
      UniProt Number
      Molecular Weight~160 kDa observed. Target band size appears larger than the calculated molecular weights of 57.56/53,80 kDa (pro-/mature isoform 1; BGPa, CEACAM1-4L, TM1-CEA), 45.95/42.19 kDa (pro-/mature isoform 2; BGPg, CEACAM1-4C1), 35.30/31.54 kDa (pro-/mature isoform 3; BGPh, CEACAM1-3), 38.58/34.81 kDa (pro-/mature isoform 4; BGPi, CEACAM1-3C2), 50.35/46.58 kDa (pro-/mature isoform 5; BGPy, CEACAM1-3AL), 46.91/43.15 kDa (pro-/mature isoform 6; BGPb, CEACAM1-3L, TM2-CEA), 27.43/23.67 kDa (pro-/mature isoform 7; BGPx, CEACAM1-1L), 50.52/46.76 kDa (pro-/mature isoform 8; BGPc, CEACAM1-4S, TM3-CEA), 43.06/39.30 kDa (pro-/mature isoform 9; BGPz, CEACAM1-3AS), 51.15/47.38 kDa (pro-/mature isoform 10), 39.87/36.11 kDa ((pro-/mature isoform 11; BGPd, CEACAM1-3S) due to glycosylation. Uncharacterized bands may be observed in some lysates.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting in HepG2 cell lysate.

      Western Blotting Analysis: 2 µg/mL of this antibody detected CEACAM1/CD66a in 10 µg of HepG2 cell lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MABT397 04055977053012

      Documentation

      Anti-CEACAM1/CD66a Antibody, clone B3-17 SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-CEACAM1/CD66a Antibody, clone B3-17 Certificates of Analysis

      TitleLot Number
      Anti-CEACAM1/CD66a, clone B3-17 - Q2464792 Q2464792
      Anti-CEACAM1/CD66a, clone B3-17 - 3218876 3218876
      Anti-CEACAM1/CD66a, clone B3-17 - 3808805 3808805
      Anti-CEACAM1/CD66a, clone B3-17 - 3943917 3943917
      Anti-CEACAM1/CD66a, clone B3-17 - 4030988 4030988
      Anti-CEACAM1/CD66a, clone B3-17 -2569194 2569194
      Anti-CEACAM1/CD66a, clone B3-17 -2612286 2612286
      Anti-CEACAM1/CD66a, clone B3-17 -2640031 2640031
      Anti-CEACAM1/CD66a, clone B3-17 -2650910 2650910
      Anti-CEACAM1/CD66a, clone B3-17 -2653931 2653931

      References

      Reference overviewPub Med ID
      Carcinoembryonic antigen (CEA)-related cell adhesion molecules are co-expressed in the human lung and their expression can be modulated in bronchial epithelial cells by non-typable Haemophilus influenzae, Moraxella catarrhalis, TLR3, and type I and II interferons.
      Klaile, E; Klassert, TE; Scheffrahn, I; Müller, MM; Heinrich, A; Heyl, KA; Dienemann, H; Grünewald, C; Bals, R; Singer, BB; Slevogt, H
      Respiratory research  14  85  2013

      Show Abstract
      23941132 23941132
      Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior.
      Muturi, HT; Dreesen, JD; Nilewski, E; Jastrow, H; Giebel, B; Ergun, S; Singer, BB
      PloS one  8  e74654  2013

      Show Abstract
      24040308 24040308

      Related Products & Applications

      Related Products

      Catalogue Number Description  
      FCMAB204F Milli-Mark™ Anti-CD66abce-FITC Antibody, clone Kat4c Show Pricing & Availability
      MABT65 Anti-CEACAM1 Antibody, clone 4D1/C2 Show Pricing & Availability

      Categories

      Life Science Research > Antibodies and Assays > Primary Antibodies